Evidence map›Paper›PMID 30002711›Full record

ArticleArchives of medical science : AMS2018

Pretreatment with obestatin inhibits the development of acetic acid-induced colitis in rats.

Aleksandra Matuszyk, Piotr Ceranowicz, Zygmunt Warzecha, Jakub Cieszkowski, Krystyna Gałązka, Joanna Bonior, Jolanta Jaworek, Peter Christopher Konturek, Krzysztof Gil, Artur Dembiński

Open access · goldAbstract read
In one paragraph

Article in Archives of medical science : AMS, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Aleksandra MatuszykDepartment of Physiology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.
Piotr CeranowiczDepartment of Physiology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.
Zygmunt WarzechaDepartment of Physiology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.
Jakub CieszkowskiDepartment of Physiology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.
Krystyna GałązkaDepartment of Pathomorphology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.
Joanna BoniorDepartment of Medical Physiology, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland.
Jolanta JaworekDepartment of Medical Physiology, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland.
Peter Christopher KonturekDepartment of Internal Medicine II, Thuringia-Clinic Saalfeld, Teaching Hospital of the University of Jena, Saalfeld, Germany.
Krzysztof GilDepartment of Pathophysiology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.
Artur DembińskiDepartment of Physiology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.
Jagiellonian University · PLJena University Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionObestatin is a 23-amino acid peptide derived from proghrelin, a common prohormone for ghrelin and obestatin. Previous studies have shown that obestatin exhibits some protective and therapeutic effects in the pancreas and stomach. The aim of this study was to examine the effect of pretreatment with obestatin on the development of acetic acid-induced colitis. MATERIAL AND

methodsStudies were performed on Wistar rats. Before induction of colitis, rats were treated intraperitoneally with saline or obestatin, administered twice at a dose of 4, 8 or 16 nmol/kg/dose. The first dose of saline or obestatin was administered 8 h before the induction of colitis, the second one 7 h after the first dose. Colitis was induced by enema with 1 ml of 4% acetic acid solution. The severity of colitis was assessed 1 or 24 h after administration of enema.

resultsPretreatment with obestatin administered at a dose of 8 or 16 nmol/kg/dose significantly reduced the area of mucosal damage evoked by enema with acetic acid (

conclusionsPretreatment with obestatin exhibited a protective effect in the colon, leading to a reduction of colonic damage in acetic acid-induced colitis. This effect was associated with an improvement of mucosal blood flow, an increase in mucosal cell proliferation, and a decrease in local inflammation.

Indexed as

blood flowcell proliferationinterleukin-1βmyeloperoxidase

Identifiers

PMID30002711
PMCPMC6040133
OpenAlexW2395755907

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.